ctrl K

Price Alert

Immunovant Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

14.81

-0.45 (-2.95%)

At close: Aug 19, 2025, 3:59 PM

14.82

0.03%

After-hours: Aug 19, 2025, 06:20 PM EDT

Immunovant Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	713.97M	635.37M	376.53M	493.82M	400.15M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	7.62M	n/a	n/a	n/a	n/a
Receivables	2.51M	5.5M	885K	12.86M	1.14M
Inventory	n/a	n/a	-0.00	-0.00	0.00
Other Current Assets	51.18M	24.9M	n/a	n/a	n/a
Total Current Assets	767.66M	665.77M	404.33M	512.93M	409.01M
Property-Plant & Equipment	942K	595K	1.5M	2.63M	3.48M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.56M	595K	1.5M	2.63M	3.48M
Total Assets	776.22M	666.37M	405.84M	515.56M	412.49M
Account Payables	17.66M	7.16M	1.35M	18.63M	2.43M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	98K	n/a	n/a	n/a	1.18M
Other Current Liabilities	15.62M	14.74M	350K	171K	10.84M
Total Current Liabilities	68.78M	48.61M	43.3M	44.52M	18.77M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	-347K	n/a	n/a	n/a
Total Long-Term Liabilities	1.1M	347K	47K	1.22M	2.24M
Total Liabilities	68.78M	48.61M	43.34M	45.74M	21.01M
Total Debt	98K	138K	1.22M	2.36M	3.42M
Common Stock	16K	14K	13K	12K	10K
Retained Earnings	-1.24B	-825.68M	-566.35M	-355.39M	-198.66M
Comprehensive Income	1.46M	1.91M	852K	404K	-298K
Shareholders Equity	707.45M	617.76M	362.49M	469.82M	391.48M
Total Investments	n/a	n/a	n/a	n/a	n/a